Table 1 Patient baseline characteristics
Total number of patients (n) | 41 |
|---|---|
Mean age, years (SD) | 59.6 (8.6) |
Male sex (%) | 53.7 |
BMI (Kg/m2, SD) | 26.9 (4.2) |
Diabetes mellitus (n, %) | 4 (9.8) |
Smoking habits (n, %) | |
Non-smokers | 16 (39.0) |
Former smoker | 11 (26.8) |
Current smoker | 14 (34.2) |
Smoking pack-years (median, IQR) | 17.5 (14–31) |
Comorbidities (n, %) | |
None | 21 (51.2) |
Obesity | 2 (4.9) |
Cardiovascular | 9 (22.0) |
Respiratory | 4 (9.8) |
Any cancer | 2 (4.9) |
Multiple pathology | 3 (7.3) |
Family history of CRC (n, %) | 12 (29.3) |
Personal history of CRC (n, %) | 0 |
Personal history of abdominal surgery (n, %) | 17 (41.5) |
Colonoscopy indication (n, %) | |
CRC screening | 19 (46.3) |
Surveillance for colonic neoplasia | 10 (24.4) |
Diagnosis or clinical symptoms | 6 (14.6) |
Family history of CRC screening | 5 (12.2) |
Therapeutic colonoscopy | 1 (2.4) |
Baseline inclusion criteria (n, %) a | |
One or more serrated polyp larger than 10 mm | 26 (63.4) |
Three or more serrated polyps | 15 (36.6) |
Type of colonoscope at baseline examination | |
165 Olympus series | 4 (9.8) |
180 Olympus series | 14 (34.1) |
190 Olympus series | 23 (56.1) |
Mean time from baseline to colonoscopy review (months, 95% CI) | 6.7 (5.2–8.3) |